Edity Therapeutics Israeli Company
Edity is developing an exciting new platform that harnesses the immune system to deliver therapeutic proteins direct to the cytoplasm of target cells to reprogram cells and tissue back to health.
Health Tech & Life Sciences
Biotechnology
Genetics
Medical Device
Therapeutics
Alternatives
No alternatives listed yet.
Suggest an Alternative
Founders
Parent Companies/Investors
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/edity-therapeutics
[2]
crunchbase.com
- https://www.crunchbase.com/organization/edity-therapeutics
External links are provided for reference and verification purposes.